Table 1 One-year and two-year mortality rates among men with newly managed prostate cancer in 2009 by age and comparison with all male general scheme beneficiaries aged 40 and over, according to age after two years
From: Prostate cancer outcomes in France: treatments, adverse effects and two-year mortality
40-49 | 50-54 | 55-59 | 60-64 | 65-69 | 70-74 | 75-79 | 80-84 | 85 and over | All ages | |
|---|---|---|---|---|---|---|---|---|---|---|
Patients with cancer | ||||||||||
N | 478 | 1,567 | 4,079 | 7,371 | 7,435 | 7,876 | 6,663 | 4,351 | 3,640 | 43,460 |
% | 1.1 | 3.6 | 9.4 | 17.0 | 17.1 | 18.1 | 15.3 | 10.0 | 8.4 | 100.0 |
One-year follow-up | ||||||||||
Patients still alive* | 443 | 1,481 | 3,857 | 7,026 | 7,070 | 7,368 | 6,022 | 3,568 | 2,526 | 39,361 |
Deceased | ||||||||||
N | 15 | 40 | 101 | 186 | 242 | 392 | 532 | 727 | 1,047 | 3,282 |
% | 3.3 | 2.6 | 2.6 | 2.6 | 3.3 | 5.1 | 8.1 | 16.9 | 29.3 | 4.6** |
Two-year follow-up | ||||||||||
Patients still alive* | 414 | 1,433 | 3,727 | 6,782 | 6,792 | 7,033 | 5,554 | 3,106 | 1,893 | 36,734 |
Deceased | ||||||||||
N | 31 | 71 | 192 | 369 | 456 | 665 | 948 | 1,159 | 1,656 | 5,547 |
% | 7.0 | 4.7 | 4.9 | 5.2 | 6.3 | 8.6 | 14.6 | 27.2 | 46.7 | 8.4** |
SMR§ | 11.4 | 3.7 | 2.6 | 2.1 | 1.9 | 1.8 | 1.9 | 2.1 | 1.9 | 2.0** |